Entero Healthcare Solutions (NSE:ENTERO) Long-Term Debt: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ENTERO Entero Healthcare Solutions Ltd NSE:ENTERO
67 GF Score
Price ₹1,416.60
GF Value ₹1,735.94
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Entero Healthcare Solutions Long-Term Debt?

Entero Healthcare Solutions NSE:ENTERO -2.17% 67 Long-Term Debt is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:ENTERO with a GF Score™ of 67/100 and a GF Value™ of ₹1,735.94 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Entero Healthcare Solutions's Long-Term Debt for the quarter that ended in Jun. 2026 was ₹0 Mil.

Entero Healthcare Solutions's quarterly Long-Term Debt increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹1,226 Mil) but then declined from Mar. 2026 (₹1,226 Mil) to Jun. 2026 (₹0 Mil).

Entero Healthcare Solutions's annual Long-Term Debt declined from Mar. 2024 (₹455 Mil) to Mar. 2025 (₹0 Mil) but then increased from Mar. 2025 (₹0 Mil) to Mar. 2026 (₹1,226 Mil).

Entero Healthcare Solutions  (NSE:ENTERO) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Entero Healthcare Solutions Long-Term Debt Related Terms

Entero Healthcare Solutions Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Entero Healthcare Solutions's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entero Healthcare Solutions Long-Term Debt Chart

Entero Healthcare Solutions Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Long-Term Debt
Get a 7-Day Free Trial 371.26 310.67 455.41 0.00 1,225.60

Entero Healthcare Solutions Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 76.62 0.00 1,225.60 0.00
NSE:ENTERO
67GF Score
Entero Healthcare Solutions Ltd NSE:ENTERO
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ₹0 Mil mean?
Entero Healthcare Solutions (NSE:ENTERO) has a Long-Term Debt of ₹0 Mil as of Jun. 2026.
Is Entero Healthcare Solutions' Long-Term Debt too high?
Entero Healthcare Solutions' current Long-Term Debt is ₹0 Mil. Overall, Entero Healthcare Solutions has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Entero Healthcare Solutions' Long-Term Debt compare to MCK and COR?
Entero Healthcare Solutions' Long-Term Debt of ₹0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Distribution company?
A good Long-Term Debt depends on the Medical Distribution industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Entero Healthcare Solutions's current Long-Term Debt is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entero Healthcare Solutions stock overvalued right now?
Based on GuruFocus' analysis, Entero Healthcare Solutions (NSE:ENTERO) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,735.94, compared to a current price of ₹1,416.60 — trading 18.4% below its estimated fair value. The current Long-Term Debt is ₹0 Mil. Entero Healthcare Solutions' overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Entero Healthcare Solutions (NSE:ENTERO), the current Long-Term Debt is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Entero Healthcare Solutions (NSE:ENTERO) Overvalued in 2026?

Based on GuruFocus' analysis, Entero Healthcare Solutions stock appears to be undervalued. The current stock price of ₹1,416.60 is trading 18.4% below its estimated GF Value™ of ₹1,735.94. GuruFocus considers Entero Healthcare Solutions to be Modestly Undervalued.

Key valuation signals for NSE:ENTERO:

  • Long-Term Debt: ₹0 Mil
  • GF Value™: ₹1,735.94 vs. price of ₹1,416.60 (18.4% below fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the NSE:ENTERO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Entero Healthcare Solutions Business Description

Other Exchanges 544122:India
Address Bandra Kurla Complex, Trade Centre, Unit No. 605 & 606, 6th Floor, Bandra East, Mumbai, MH, IND, 400051
Entero Healthcare Solutions Ltd is a healthcare products distributor in India. It is involved in the business of distribution and marketing of pharmaceutical and surgical products and allied services. Geographically, the company derives a majority of its revenue from the domestic market.
67GF Score

Get the complete analysis for NSE:ENTERO

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,416.60
Price
₹1,735.94
GF Value